Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vertex Pharmaceuticals Ownership Summary


Vertex Pharmaceuticals is owned by 89.56% institutional investors, 0.08% insiders, and 10.36% retail investors. Capital world investors is the largest institutional shareholder, holding 10.34% of VRTX shares. American Funds Growth Fund of Amer A is the top mutual fund, with 3.65% of its assets in Vertex Pharmaceuticals shares.

VRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVertex Pharmaceuticals89.56%0.08%10.36%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital world investors26.71M10.34%$12.52B
Vanguard group22.98M8.90%$10.77B
Blackrock21.31M8.25%$9.99B
State street11.73M4.54%$5.50B
Fmr10.73M4.16%$5.03B
Capital research global investors8.54M3.31%$4.00B
Alliancebernstein7.22M2.80%$3.38B
Jpmorgan chase6.60M2.56%$3.09B
Geode capital management6.33M2.45%$2.96B
Jennison associates4.32M1.67%$1.74B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp330.00K11.93%$154.68M
Bridger management41.05K9.90%$19.24M
Provident investment management159.86K6.82%$74.93M
Montchanin asset management10.74K4.76%$5.03M
Bellevue group593.46K4.52%$278.17M
Healthinvest partners ab15.10K4.31%$7.08M
Guoline advisory pte79.70K3.99%$37.36M
First turn management50.69K3.87%$23.76M
Aimz investment advisors21.47K3.61%$10.06M
Mcrae capital management33.52K3.58%$15.71M

Top Buyers

HolderShares% AssetsChange
Norges bank3.43M0.24%3.43M
Capital research global investors8.54M0.88%2.80M
Capital world investors26.71M2.04%1.14M
Wcm investment management1.09M1.03%1.09M
Jpmorgan chase6.60M0.25%581.66K

Top Sellers

HolderShares% AssetsChange
Price t rowe associates inc /md/2.21M0.12%-2.28M
Jennison associates4.32M1.06%-1.23M
Blackrock21.31M0.23%-648.44K
Wellington management group llp4.09M0.34%-463.78K
Pictet asset management sa563.36K0.30%-434.94K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.43M0.24%3.43M$1.61B
Wcm investment management1.09M1.03%1.09M$435.90M
Mirae asset global etfs194.85K0.22%194.85K$91.34M
Carmignac gestion185.25K1.49%185.25K$86.85M
Baillie gifford167.62K0.06%167.62K$78.56M

Sold Out

HolderChange
Mine & arao wealth creation & management, llc.-1.00
Mcclarren financial advisors-1.00
Tfo-tdc-2.00
Triad wealth partners-4.00
Perkins coie trust-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241,575-1.25%231,077,223-1.65%891.08%726-11.68%56810.29%
Jun 30, 20241,5701.88%234,312,9101.05%901.13%8135.31%505-1.17%
Mar 31, 20241,5413.35%231,875,378-1.27%891.08%772-2.77%5116.24%
Dec 31, 20231,49112.02%234,856,0361.31%911.13%79427.65%4817.37%
Sep 30, 20231,3310.91%231,829,251-2.07%891.06%6220.32%448-7.63%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds Growth Fund of Amer A9.40M3.65%1.30M
Capital Group Growth Fnd of Amer Comp9.40M3.65%1.30M
Vanguard Total Stock Mkt Idx Inv8.07M3.13%-42.24K
Vanguard Institutional 500 Index Trust6.97M2.71%34.91K
Invesco QQQ Trust5.22M2.03%56.98K
American Funds American Balanced A4.93M1.91%-55.00K
American Funds New Perspective A4.03M1.56%345.03K
Capital Group New Perspective Comp3.69M1.43%-64.65K
Fidelity Contrafund3.44M1.33%4.44K
SPDR® S&P 500® ETF Trust3.22M1.25%24.16K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 15, 2024ALTSHULER DAVID EVP, Chief Scientific OfficerSell$7.18K
Nov 11, 2024WAGNER CHARLES F JR EVP & Chief Financial OfficerSell$1.55M
Nov 08, 2024Kewalramani Reshma CEO & PresidentSell$7.83M
Oct 02, 2024Biller Jonathan EVP and Chief Legal OfficerSell$461.20K
Aug 30, 2024LEIDEN JEFFREY M Executive ChairmanSell$1.89M

Insider Transactions Trends


DateBuySell
2024 Q4-4
2024 Q3-9
2024 Q2-17
2024 Q1-30
2023 Q4-18

VRTX Ownership FAQ


Who Owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals shareholders are primarily institutional investors at 89.56%, followed by 0.08% insiders and 10.36% retail investors. The average institutional ownership in Vertex Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Vertex Pharmaceuticals falls below.

Who owns the most shares of Vertex Pharmaceuticals?

Vertex Pharmaceuticals’s largest shareholders are Capital world investors (26.71M shares, 10.34%), Vanguard group (22.98M shares, 8.90%), and Blackrock (21.31M shares, 8.25%). Together, they hold 27.50% of Vertex Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vertex Pharmaceuticals?

Yes, BlackRock owns 8.25% of Vertex Pharmaceuticals, totaling 21.31M shares as of Jun 2024. This represents 0.23% of BlackRock's total assets, with a market value of 9.99B$. In the last quarter, BlackRock decreased its holdings by -648K shares, a -2.95% change.

Who is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.93% of its assets in 330K Vertex Pharmaceuticals shares, valued at 154.68M$.

Who is the top mutual fund holder of Vertex Pharmaceuticals shares?

American Funds Growth Fund of Amer A is the top mutual fund holder of Vertex Pharmaceuticals shares, with 3.65% of its total shares outstanding invested in 9.4M Vertex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools